Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

3 Healthcare Stocks to Buy and Hold for the Next 10 Years


The healthcare sector is unlikely to become obsolete anytime soon, but individual companies can very much get left behind if they fail to keep up with the changing dynamics of the industry. That's one of the things investors looking for companies within this sector should watch out for on a regular basis.

Let's look at three healthcare stocks that are leaders or innovators in their respective niches and could provide excellent returns in the next 10 years: Vertex Pharmaceuticals (NASDAQ: VRTX), Moderna (NASDAQ: MRNA), and Gilead Sciences (NASDAQ: GILD).

Vertex Pharmaceuticals has soundly beaten the market in the past 10 years, and the company is in an excellent position to do so in the next decade. Here are two reasons why. First, Vertex's core cystic fibrosis franchise should continue to perform well. The company's most important product is Trikafta, which can treat up to 90% of CF patients.

Continue reading


Source Fool.com

Vertex Pharmaceuticals Inc. Stock

€433.10
0.300%
The Vertex Pharmaceuticals Inc. stock is trending slightly upwards today, with an increase of €1.30 (0.300%) compared to yesterday's price.
With 59 Buy predictions and 2 Sell predictions Vertex Pharmaceuticals Inc. is one of the favorites of our community.
As a result the target price of 450 € shows a slightly positive potential of 3.9% compared to the current price of 433.1 € for Vertex Pharmaceuticals Inc..
Like: 0
Share

Comments